E. Elliott

An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland

S. Chandran, S. Colville, S. Pal, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Therapeutic Targeting of Proteostasis in Amyotrophic Lateral Sclerosis—a Systematic Review and Meta-Analysis of Preclinical Research

S. Chandran, G. Hardingham, Fergal M. Waldron, 2020, Frontiers in Neuroscience.

Nutritional Support for Pediatric Severe Traumatic Brain Injury

M. Shoykhet, M. Bell, E. Elliott, 2022, Frontiers in Pediatrics.

Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease

S. Chandran, J. Chataway, M. Parmar, 2022, BMJ Open.

Neuronal clusterin expression is associated with cognitive protection in amyotrophic lateral sclerosis

S. Chandran, T. Bak, S. Abrahams, 2019, Neuropathology and applied neurobiology.

NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis

Colin Smith, S. Chandran, S. Abrahams, 2021, The Journal of pathology.

Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective

M. Macleod, S. Chandran, J. Chataway, 2021, Brain communications.

Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus

Ashutosh Kumar Singh, S. Chandran, J. Chataway, 2023, BMJ Open.

A Systematic Approach to Identify Neuroprotective Interventions for Motor Neuron Disease

Ashutosh Kumar Singh, S. Chandran, J. Chataway, 2022, medRxiv.